Kroegel C, Venge P, Matthys H, Barnes P J
Department of Thoracic Medicine, Brompton Hospital, University of London, United Kingdom.
Pneumologie. 1990 Feb;44 Suppl 1:234-5.
Incubation of purified human eosinophil granulocytes (greater than 93%) with the platelet activating factor (PAF), led at concentrations of 1 pM to 10 microM, to a non-cytotoxic and dose-dependent liberation of proteins both from the "small" and the "specific" granules. The mean EC50 for this PAF-induced effect was 1.47 nM (n = 9), with a maximum at 100 nM PAF. The degranulating effect of PAF can be inhibited competitively by the specific PAF-receptor antagonist, WEB 2086 (KB between 12 and 13 nM), and is Ca2(+)-dependent.
将纯化的人嗜酸性粒细胞(纯度大于93%)与血小板活化因子(PAF)一起孵育,在1皮摩尔至10微摩尔的浓度范围内,会导致从“小”颗粒和“特异性”颗粒中以非细胞毒性且剂量依赖性的方式释放蛋白质。PAF诱导这种效应的平均半数有效浓度(EC50)为1.47纳摩尔(n = 9),在100纳摩尔PAF时达到最大值。PAF的脱颗粒效应可被特异性PAF受体拮抗剂WEB 2086竞争性抑制(解离常数KB在12至13纳摩尔之间),且依赖于Ca2⁺ 。